Abstract:Following the publication of this article, a concerned reader drew to the authors' attention that a pair of the 24 h scratch‑wound assay data panels in Fig. 4A, and three of the migration and invasion assay data panels in Fig. 4B, exhibited overlapping sections, suggesting that data which were intended to have shown the results from differently performed experiments had originated from the same sources. In addition, the total number of cases for the LSCC sample data in Table II did not reflect the sum of the samples indicated in the 'negative', 'positive' and 'strong positive' categories. After having consulted their original data, the authors have realized that Table II and Fig. 4 contained some inadvertent errors: The authors divided their control group data into two subgroups, namely the non‑transfection and negative‑shRNA groups, although they overlooked details of the filing system they had devised for saving the data, and mistakenly included images from the non‑transfection group in with the negative‑shRNA group due to unclear file labeling. Moreover, in Table II, the data value for the 'positive' stained samples should have been written as '43', not '44'. The corrected versions of Table II and Fig. 4, which now shows the corrected data for the 'Negative‑shRNA / 24 h' experiment in Fig. 4A and the 'Non‑transfection / Invasion' and 'Negative‑shRNA / Migration' experiments in Fig. 4B, are shown below and on the next page, respectively. The authors sincerely apologize for the errors that were introduced during the preparation of this table and this figure, thank the Editor of for granting them the opportunity to publish this corrigendum, and regret any inconvenience that these mistakes may have caused to the readership. [Oncology Reports 34: 3111‑3119, 2015; DOI: 10.3892/or.2015.4274].

[Corrigendum] Propofol‐induced HOXA11‐AS promotes proliferation, migration and invasion, but inhibits apoptosis in hepatocellular carcinoma cells by targeting miR‐4458

[Corrigendum] Linc00961 Inhibits the Proliferation and Invasion of Skin Melanoma by Targeting the Mir‑367/pten Axis.

[Corrigendum] Roles of the H19/microRNA‑675 Axis in the Proliferation and Epithelial‑mesenchymal Transition of Human Cutaneous Squamous Cell Carcinoma Cells

[Corrigendum] MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma

[Corrigendum] MicroRNA‑92a Contributes to Tumor Growth of Human Hepatocellular Carcinoma by Targeting FBXW7

[Corrigendum] Knockdown of circ_0067934 inhibits gastric cancer cell proliferation, migration and invasion via the miR‑1301‑3p/KIF23 axis

[Corrigendum] Effects of miR‑340 overexpression and knockdown on the proliferation and metastasis of NSCLC cell lines

[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer

[Corrigendum] High PLK4 Expression Promotes Tumor Progression and Induces Epithelial‑mesenchymal Transition by Regulating the Wnt/β‑catenin Signaling Pathway in Colorectal Cancer

[Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain

[Corrigendum] Exogenous Hydrogen Sulfide Exerts Proliferation, Anti-Apoptosis, Migration Effects and Accelerates Cell Cycle Progression in Multiple Myeloma Cells Via Activating the Akt Pathway

[Corrigendum] Mir‑490‑5p Regulates the Proliferation, Migration, Invasion and Epithelial‑mesenchymal Transition of Pharyngolaryngeal Cancer Cells by Targeting Mitogen‑activated Protein Kinase Kinase Kinase 9

[Corrigendum] microRNA‐181a‐5p functions as an oncogene in renal cell carcinoma

[Corrigendum] MicroRNA-375 inhibits glioma cell proliferation and migration by downregulating RWDD3 in vitro.

[Corrigendum] Long Non‑coding RNA AC245100.4 Promotes Prostate Cancer Tumorigenesis Via the Microrna‑145‑5p/rbbp5 Axis.

[Corrigendum] miR‐26a inhibits ovarian cancer cell proliferation, migration and invasion by targeting TCF12

[Corrigendum] miR‐135 regulated breast cancer proliferation and epithelial‐mesenchymal transition acts by the Wnt/β‐catenin signaling pathway

[Corrigendum] Downregulation of Notch1 induces apoptosis and inhibits cell proliferation and metastasis in laryngeal squamous cell carcinoma.

[Corrigendum] Celecoxib inhibits the epithelial‐to‐mesenchymal transition in bladder cancer via the miRNA‐145/TGFBR2/Smad3 axis

[Corrigendum] Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level

[Corrigendum] HIF‑1α Promotes ZEB1 Expression and EMT in a Human Bladder Cancer Lung Metastasis Animal Model